These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1945322)

  • 21. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence.
    Wei RL; Cheng JW; Cai JP
    Ophthalmologica; 2008; 222(1):27-31. PubMed ID: 18097177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orbital Radiotherapy Combined With Corticosteroid Treatment for Thyroid Eye Disease-Compressive Optic Neuropathy.
    Gold KG; Scofield S; Isaacson SR; Stewart MW; Kazim M
    Ophthalmic Plast Reconstr Surg; 2018; 34(2):172-177. PubMed ID: 29517594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Balanced (endoscopic medial and transcutaneous lateral) orbital decompression in Graves' orbitopathy.
    Hernández-García E; San-Román JJ; González R; Nogueira A; Genol I; Stoica B; Toledano N; Plaza G
    Acta Otolaryngol; 2017 Nov; 137(11):1183-1187. PubMed ID: 28741406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of corticosteroids versus other treatments for Graves' ophthalmopathy: a quantitative evaluation.
    Abalkhail S; Doi SA; Al-Shoumer KA
    Med Sci Monit; 2003 Nov; 9(11):CR477-83. PubMed ID: 14586273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An individualized approach to orbital decompression in Graves' orbitopathy.
    Hurwitz JJ; Birt D
    Arch Ophthalmol; 1985 May; 103(5):660-5. PubMed ID: 3838890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy.
    Baldeschi L; MacAndie K; Koetsier E; Blank LE; Wiersinga WM
    Am J Ophthalmol; 2008 Mar; 145(3):534-540. PubMed ID: 18191092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
    Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results and prognostic factors in retrobulbar radiotherapy combined with systemic corticosteroids for endocrine orbitopathy (Graves' disease).
    Staar S; Müller RP; Hammer M; Nolte M
    Front Radiat Ther Oncol; 1997; 30():206-17. PubMed ID: 9205903
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease.
    Claridge KG; Ghabrial R; Davis G; Tomlinson M; Goodman S; Harrad RA; Potts MJ
    Eye (Lond); 1997; 11 ( Pt 5)():717-22. PubMed ID: 9474324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orbital fat removal. Decompression for Graves orbitopathy.
    Trokel S; Kazim M; Moore S
    Ophthalmology; 1993 May; 100(5):674-82. PubMed ID: 8493010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of graves' orbitopathy after treatment.
    Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
    Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspective--Part I: the Mayo Orbital Radiotherapy for Graves Ophthalmopathy (ORGO) study: lessons learned.
    Bartley GB; Gorman CA
    Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):170-2. PubMed ID: 12021644
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lateral orbital decompression for Graves' orbitopathy. Indication, surgical technique, and treatment success].
    Fichter N; Schittkowski MP; Vick HP; Guthoff RF
    Ophthalmologe; 2004 Apr; 101(4):339-49. PubMed ID: 15034737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of radiation therapy in Graves' ophthalmopathy.
    Chowdhury AD; Moriarty MJ
    Australas Radiol; 1996 Nov; 40(4):422-3. PubMed ID: 8996904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis.
    Stiebel-Kalish H; Robenshtok E; Hasanreisoglu M; Ezrachi D; Shimon I; Leibovici L
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2708-16. PubMed ID: 19491222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical decompression in endocrine orbitopathy. Visual evoked potential evaluation and effect on the optic nerve.
    Clauser LC; Tieghi R; Galie' M; Franco F; Carinci F
    J Craniomaxillofac Surg; 2012 Oct; 40(7):621-5. PubMed ID: 22424910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy in benign orbital disease. II: Ophthalmic Graves' disease and orbital histiocytosis X.
    Harnett AN; Doughty D; Hirst A; Plowman PN
    Br J Ophthalmol; 1988 Apr; 72(4):289-92. PubMed ID: 3259894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orbital irradiation for thyroid-associated orbitopathy: conventional dose, low dose or no dose?
    Perros P; Krassas GE
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):689-91. PubMed ID: 12072037
    [No Abstract]   [Full Text] [Related]  

  • 40. Reactivation of Graves' orbitopathy after rehabilitative orbital decompression.
    Baldeschi L; Lupetti A; Vu P; Wakelkamp IM; Prummel MF; Wiersinga WM
    Ophthalmology; 2007 Jul; 114(7):1395-402. PubMed ID: 17320178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.